124 related articles for article (PubMed ID: 9453997)
1. Tumor-associated trypsin inhibitor (TATI) and renal function.
Tramonti G; Ferdeghini M; Donadio C; Annichiarico C; Norpoth M; Bianchi R; Bianchi C
Kidney Int Suppl; 1997 Dec; 63():S179-81. PubMed ID: 9453997
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function.
Tramonti G; Ferdeghini M; Annichiarico C; Donadio C; Norpoth M; Mantuano E; Bianchi C
J Nephrol; 2003; 16(5):663-72. PubMed ID: 14733412
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of tumor associated trypsin inhibitor (TATI) and glomerular filtration rate.
Tramonti G; Ferdeghini M; Donadio C; Annichiarico C; Norpoth M; Bianchi R; Bianchi C
Ren Fail; 1998 Mar; 20(2):295-302. PubMed ID: 9574455
[TBL] [Abstract][Full Text] [Related]
4. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia.
Tramonti G; Ferdeghini M; Donadio C; Norpoth M; Annichiarico C; Bianchi R; Bianchi C
Cancer Detect Prev; 2000; 24(1):86-90. PubMed ID: 10757127
[TBL] [Abstract][Full Text] [Related]
5. Serum tumour-associated trypsin inhibitor (TATI) and renal function.
Tramonti G; Donadio C; Ferdeghini M; Annichiarico C; Norpoth M; Bianchi R; Bianchi C
Scand J Clin Lab Invest; 1996 Nov; 56(7):653-6. PubMed ID: 8981662
[TBL] [Abstract][Full Text] [Related]
6. Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria.
Tramonti G; Cipollini I; Annichiarico C; Lorusso P; Panicucci E; Mariani G; Barsotti G
J Nephrol; 2012; 25(6):976-82. PubMed ID: 22307441
[TBL] [Abstract][Full Text] [Related]
7. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
[TBL] [Abstract][Full Text] [Related]
8. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
[TBL] [Abstract][Full Text] [Related]
9. Effects of cigarette smoking on serum fluoride concentrations and renal function integrity after 1 MAC-h sevoflurane anaesthesia.
Laisalmi M; Kokki H; Soikkeli A; Markkanen H; Yli-Hankala A; Rosenberg P; Lindgren L
Acta Anaesthesiol Scand; 2006 Sep; 50(8):982-7. PubMed ID: 16923094
[TBL] [Abstract][Full Text] [Related]
10. [Determination of tumor-associated trypsin inhibitor (TATI) in subjects with gastrointestinal diseases. Preliminary data].
Piantino P; Mosso R; Polloni R; Cerchier A; Gennaretti G; Daziano E
Minerva Med; 1989 Mar; 80(3):199-203. PubMed ID: 2717042
[TBL] [Abstract][Full Text] [Related]
11. [Is the serum level of beta 2 microglobulin a better marker of glomerular filtration than blood creatinine?].
François B; Assenat H; Cahen R; Bizollon C
Nephrologie; 1982; 3(3):116-8. PubMed ID: 6183598
[TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
13. Relationship between renal function and blood level of chromogranin A.
Tramonti G; Ferdeghini M; Annichiarico C; Norpoth M; Donadio C; Bianchi R; Bianchi C
Ren Fail; 2001; 23(3-4):449-57. PubMed ID: 11499560
[TBL] [Abstract][Full Text] [Related]
14. Renal concentrating capacity as a marker for glomerular filtration rate.
García Nieto VM; Yanes MI; Zamorano MM; González MJ; Aros CP; Garin EH
Acta Paediatr; 2008 Jan; 97(1):96-9. PubMed ID: 18076717
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A
Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443
[TBL] [Abstract][Full Text] [Related]
16. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
17. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?
Ozer BA; Dursun B; Baykal A; Gultekin M; Suleymanlar G
Ren Fail; 2005; 27(3):247-53. PubMed ID: 15957539
[TBL] [Abstract][Full Text] [Related]
18. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
19. Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays.
Janeiro E; Guimarães J; Stenman UH; Catarino M; Itkonen O
Clin Chim Acta; 2012 Aug; 413(15-16):1244-8. PubMed ID: 22507084
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function.
Randers E; Erlandsen EJ; Pedersen OL; Hasling C; Danielsen H
Clin Nephrol; 2000 Sep; 54(3):203-9. PubMed ID: 11020018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
